Taken together with findings that HBV-related HCC patients had the highest sPD-1 levels in this study, it is suggested that the obviously increased sPD-1 is a reflection of the activation of immune response to both the HBV and the tumor. The gene discussed is HOXD13; the disease is hepatocellular carcinoma.